299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02950116 (ClinicalTrials.gov)	March 9, 2017	11/10/2016	Lung Clearance Index (LCI) in Pediatric Patients With Obstructive Lung Disease	Lung Clearance Index in Pediatric Patients With Obstructive Lung Disease	Asthma;Bronchiectasis;Cystic Fibrosis	Device: Perform three multiple breath nitrogen washout tests (N2-MBW-test)	Universitair Ziekenhuis Brussel	NULL	Terminated	6 Years	17 Years	All	27	N/A	Belgium
2	NCT00570349 (ClinicalTrials.gov)	July 2004	6/12/2007	Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis	Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis	Cystic Fibrosis	Drug: Nitric Oxide for Inhalation;Drug: Nitrogen	Mallinckrodt	NULL	Completed	12 Years	N/A	All	18	Phase 1/Phase 2	United States